Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2025 Filed Jan 5, 2026 19:19 UTC |
Frederick Wayne A.I.Director
|
GrantRestricted Stock Units · Derivative | 35 | $258.87 | $9,060.36 |
DisclosureSEC source: 0001802241-26-000002 · form4.xml · derivative · entry 3 Frederick Wayne A.I. · CIK 0001802241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73 Underlying: Humana Common · 35 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 18:52 UTC |
Garratt John WDirector
|
GrantRestricted Stock Units · Derivative | 16 | $258.87 | $4,141.88 |
DisclosureSEC source: 0001646121-26-000003 · form4.xml · derivative · entry 3 Garratt John W · CIK 0001646121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18 Underlying: Humana Common · 16 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 18:47 UTC |
Klevorn Marcy SDirector
|
GrantRestricted Stock Units · Derivative | 28 | $258.87 | $7,248.29 |
DisclosureSEC source: 0001692367-26-000003 · form4.xml · derivative · entry 3 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53 Underlying: Humana Common · 28 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 18:24 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 357 | $258.87 | $92,415.70 |
DisclosureSEC source: 0001191504-26-000002 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,765 Underlying: Humana Common · 357 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 18:24 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 611 | $258.87 | $158,168.04 |
DisclosureSEC source: 0001191504-26-000002 · form4.xml · derivative · entry 3 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,364 Underlying: Humana Common · 611 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 14:31 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 49 | $258.87 | $12,684.51 |
DisclosureSEC source: 0001157619-26-000003 · form4.xml · derivative · entry 4 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124 Underlying: Humana Common · 49 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 14:02 UTC |
Smith GordonDirector
|
GrantRestricted Stock Units · Derivative | 10 | $258.87 | $2,588.68 |
DisclosureSEC source: 0001311487-26-000002 · form4.xml · derivative · entry 4 Smith Gordon · CIK 0001311487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10 Underlying: Humana Common · 10 shares Expires not disclosed F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · balance_after: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 14:02 UTC |
Smith GordonDirector
|
GrantRestricted Stock Units · Derivative | 122 | $258.87 | $31,581.84 |
DisclosureSEC source: 0001311487-26-000002 · form4.xml · derivative · entry 3 Smith Gordon · CIK 0001311487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Underlying: Humana Common · 122 shares Expires not disclosed F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · balance_after: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 13:57 UTC |
Bono Raquel C.Director
|
GrantRestricted Stock Units · Derivative | 34 | $258.87 | $8,801.50 |
DisclosureSEC source: 0001823759-26-000005 · form4.xml · derivative · entry 3 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72 Underlying: Humana Common · 34 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 20:12 UTC |
Mellet CelesteChief Financial Officer
|
Tax withholdingHumana Common | 1,222 | $270.16 | $330,129.41 |
DisclosureSEC source: 0001748812-25-000008 · form4.xml · nonDerivative · entry 2 Mellet Celeste · CIK 0001748812 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,454 F2 · shares: Shares disposed of represent payment of tax liability for shares vesting 12/15/25 in which no value was received in return. F1 · balance_after: Includes 27,548 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 20:12 UTC |
Mellet CelesteChief Financial Officer
|
Exercise / conversionHumana Common | 2,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001748812-25-000008 · form4.xml · nonDerivative · entry 1 Mellet Celeste · CIK 0001748812 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 20:00 UTC |
Mehta JapanChief Information Officer
|
Tax withholdingHumana Common | 470 | $270.16 | $126,972.85 |
DisclosureSEC source: 0002053625-25-000003 · form4.xml · nonDerivative · entry 2 Mehta Japan · CIK 0002053625 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,158 F2 · shares: Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return. F1 · balance_after: Includes 7,434 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 20:00 UTC |
Mehta JapanChief Information Officer
|
Exercise / conversionHumana Common | 1,194 | $0.00 | $0.00 |
DisclosureSEC source: 0002053625-25-000003 · form4.xml · nonDerivative · entry 1 Mehta Japan · CIK 0002053625 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:58 UTC |
Dintenfass DavidPresident, Enterprise Growth
|
Tax withholdingHumana Common | 918 | $270.16 | $248,002.29 |
DisclosureSEC source: 0002010288-25-000003 · form4.xml · nonDerivative · entry 2 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,316 F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/25. F2 · balance_after: Includes 11,202 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:58 UTC |
Dintenfass DavidPresident, Enterprise Growth
|
Exercise / conversionHumana Common | 2,032 | $0.00 | $0.00 |
DisclosureSEC source: 0002010288-25-000003 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:15 UTC |
Shetty Sanjay KPresident, CenterWell
|
Exercise / conversionRestricted Stock Units · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001969331-25-000003 · form4.xml · derivative · entry 7 Shetty Sanjay K · CIK 0001969331 · President, CenterWell 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 308 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_date: Restricted stock units granted to reporting person on 4/1/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F4 · derivative.expiration_date: Restricted stock units granted to reporting person on 4/1/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:15 UTC |
Shetty Sanjay KPresident, CenterWell
|
Tax withholdingHumana Common | 139 | $270.16 | $37,551.55 |
DisclosureSEC source: 0001969331-25-000003 · form4.xml · nonDerivative · entry 4 Shetty Sanjay K · CIK 0001969331 · President, CenterWell 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,847 F6 · shares: Shares disposed of represent payment of tax liability for shares vesting 12/15/25. No value was received in return. F5 · balance_after: Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:15 UTC |
Shetty Sanjay KPresident, CenterWell
|
Exercise / conversionHumana Common | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001969331-25-000003 · form4.xml · nonDerivative · entry 3 Shetty Sanjay K · CIK 0001969331 · President, CenterWell 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:15 UTC |
Shetty Sanjay KPresident, CenterWell
|
Tax withholdingHumana Common | 888 | $270.16 | $239,897.64 |
DisclosureSEC source: 0001969331-25-000003 · form4.xml · nonDerivative · entry 2 Shetty Sanjay K · CIK 0001969331 · President, CenterWell 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,678 F6 · shares: Shares disposed of represent payment of tax liability for shares vesting 12/15/25. No value was received in return. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:15 UTC |
Shetty Sanjay KPresident, CenterWell
|
Exercise / conversionHumana Common | 1,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001969331-25-000003 · form4.xml · nonDerivative · entry 1 Shetty Sanjay K · CIK 0001969331 · President, CenterWell 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:02 UTC |
O'Hara Michelle A.Chief Human Resources Officer
|
Tax withholdingHumana Common | 632 | $270.16 | $170,737.96 |
DisclosureSEC source: 0001786783-25-000009 · form4.xml · nonDerivative · entry 2 O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,634 F2 · shares: Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return. F1 · balance_after: Includes 9,865 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 19:02 UTC |
O'Hara Michelle A.Chief Human Resources Officer
|
Exercise / conversionHumana Common | 1,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001786783-25-000009 · form4.xml · nonDerivative · entry 1 O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 18:58 UTC |
Rechtin James A.President & CEO
|
Tax withholdingHumana Common | 3,372 | $270.16 | $910,962.66 |
DisclosureSEC source: 0002006065-25-000003 · form4.xml · nonDerivative · entry 2 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 27,102 F7 · shares: Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return. F6 · balance_after: Includes 14,054 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 18:58 UTC |
Rechtin James A.President & CEO
|
Exercise / conversionHumana Common | 7,707 | $0.00 | $0.00 |
DisclosureSEC source: 0002006065-25-000003 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 30,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 15:19 UTC |
Ventura Joseph CChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001768291-25-000006 · form4.xml · derivative · entry 11 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 15:19 UTC |
Ventura Joseph CChief Legal Officer
|
Tax withholdingHumana Common | 164 | $270.16 | $44,305.42 |
DisclosureSEC source: 0001768291-25-000006 · form4.xml · nonDerivative · entry 4 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,530 F10 · shares: Shares disposed of represent payment for tax liability on shares vesting vested on 12/15/25. No value was received in return. F9 · balance_after: Includes 6,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 15:19 UTC |
Ventura Joseph CChief Legal Officer
|
Exercise / conversionHumana Common | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001768291-25-000006 · form4.xml · nonDerivative · entry 3 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 15:19 UTC |
Ventura Joseph CChief Legal Officer
|
Tax withholdingHumana Common | 933 | $270.16 | $252,054.62 |
DisclosureSEC source: 0001768291-25-000006 · form4.xml · nonDerivative · entry 2 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,334 F10 · shares: Shares disposed of represent payment for tax liability on shares vesting vested on 12/15/25. No value was received in return. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 15:19 UTC |
Ventura Joseph CChief Legal Officer
|
Exercise / conversionHumana Common | 2,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001768291-25-000006 · form4.xml · nonDerivative · entry 1 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:35 UTC |
Renaudin George IIPresident, Insurance
|
Exercise / conversionRestricted Stock Units · Derivative | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001964078-25-000005 · form4.xml · derivative · entry 8 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:35 UTC |
Renaudin George IIPresident, Insurance
|
Tax withholdingHumana Common | 142 | $270.16 | $38,362.01 |
DisclosureSEC source: 0001964078-25-000005 · form4.xml · nonDerivative · entry 4 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,459 F8 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting on 12/15/25. No value was received in return. F6 · balance_after: Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:35 UTC |
Renaudin George IIPresident, Insurance
|
Exercise / conversionHumana Common | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001964078-25-000005 · form4.xml · nonDerivative · entry 3 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:35 UTC |
Renaudin George IIPresident, Insurance
|
Tax withholdingHumana Common | 830 | $270.16 | $224,228.65 |
DisclosureSEC source: 0001964078-25-000005 · form4.xml · nonDerivative · entry 2 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,241 F8 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting on 12/15/25. No value was received in return. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:35 UTC |
Renaudin George IIPresident, Insurance
|
Exercise / conversionHumana Common | 2,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001964078-25-000005 · form4.xml · nonDerivative · entry 1 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:26 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
Exercise / conversionRestricted Stock Units · Derivative | 115 | $0.00 | $0.00 |
DisclosureSEC source: 0001936662-25-000005 · form4.xml · derivative · entry 5 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 115 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. F2 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:26 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
Tax withholdingHumana Common | 53 | $270.16 | $14,318.22 |
DisclosureSEC source: 0001936662-25-000005 · form4.xml · nonDerivative · entry 4 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,734 F4 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting 12/15/25. No value was received in return. F3 · balance_after: Includes 748 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:26 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
Exercise / conversionHumana Common | 115 | $0.00 | $0.00 |
DisclosureSEC source: 0001936662-25-000005 · form4.xml · nonDerivative · entry 3 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:26 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
Tax withholdingHumana Common | 209 | $270.16 | $56,462.40 |
DisclosureSEC source: 0001936662-25-000005 · form4.xml · nonDerivative · entry 2 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,672 F4 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting 12/15/25. No value was received in return. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 14:26 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
Exercise / conversionHumana Common | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001936662-25-000005 · form4.xml · nonDerivative · entry 1 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 14:45 UTC |
Smith GordonDirector
|
Exercise / conversionHumana Common | 765 | $0.00 | $0.00 |
DisclosureSEC source: 0001311487-25-000007 · form4.xml · nonDerivative · entry 1 Smith Gordon · CIK 0001311487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 13:13 UTC |
Renaudin George IIPresident, Insurance
|
Exercise / conversionRestricted Stock Units · Derivative | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001964078-25-000003 · form4.xml · derivative · entry 6 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 13:13 UTC |
Renaudin George IIPresident, Insurance
|
Tax withholdingHumana Common | 240 | $253.12 | $60,748.80 |
DisclosureSEC source: 0001964078-25-000003 · form4.xml · nonDerivative · entry 2 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,071 F9 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting on 10/1/25. No value was received in return. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 13:13 UTC |
Renaudin George IIPresident, Insurance
|
Exercise / conversionHumana Common | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001964078-25-000003 · form4.xml · nonDerivative · entry 1 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · balance_after: Includes 11,165 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 17:07 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 69 | $257.79 | $17,787.68 |
DisclosureSEC source: 0001486426-25-000004 · form4.xml · derivative · entry 3 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 Underlying: Humana Common · 69 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 15:50 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 364 | $257.79 | $93,836.47 |
DisclosureSEC source: 0001191504-25-000005 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,408 Underlying: Humana Common · 364 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 15:37 UTC |
Smith GordonDirector
|
GrantRestricted Stock Units · Derivative | 124 | $257.79 | $31,966.27 |
DisclosureSEC source: 0001311487-25-000005 · form4.xml · derivative · entry 3 Smith Gordon · CIK 0001311487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378 Underlying: Humana Common · 124 shares Expires not disclosed F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 17:22 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
Exercise / conversionRestricted Stock Units · Derivative | 211 | $0.00 | $0.00 |
DisclosureSEC source: 0001936662-25-000003 · form4.xml · derivative · entry 3 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F2 · derivative.exercise_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25. F2 · derivative.expiration_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 17:22 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
Tax withholdingHumana Common | 97 | $248.42 | $24,096.26 |
DisclosureSEC source: 0001936662-25-000003 · form4.xml · nonDerivative · entry 2 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,881 F5 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting 8/1/25. No value was received in return. F4 · balance_after: Includes 1,203 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 17:22 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
Exercise / conversionHumana Common | 211 | $0.00 | $0.00 |
DisclosureSEC source: 0001936662-25-000003 · form4.xml · nonDerivative · entry 1 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:18 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 399 | $242.82 | $96,883.19 |
DisclosureSEC source: 0001062993-25-012449 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,044 Underlying: Humana Common · 399 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.